Evaluation of an oral uracil loading test to identify DPD‐deficient patients using a limited sampling strategy

AIM: Dihydropyrimidine dehydrogenase (DPD) deficiency can lead to severe toxicity following 5‐fluorouracil (5FU) or capecitabine (CAP) treatment. Uracil (U) can be used as a probe to determine systemic DPD activity. The present study was performed to assess the sensitivity and specificity of a U loa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Clin Pharmacol
Autors principals: van Staveren, Maurice C., van Kuilenburg, Andre B. P., Guchelaar, Henk‐Jan, Meijer, Judith, Punt, Cornelis J. A., de Jong, Robert S., Gelderblom, Hans, Maring, Jan Gerard
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Drug Metabolisms
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4767209/
https://ncbi.nlm.nih.gov/pubmed/26551538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12821
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars